Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132995) titled 'Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Firstline Therapy for Pediatric Locally Advanced and Metastatic Soft Tissue Sarcoma/Ewing Sarcoma: A Prospective, Singlearm Clinical Study' on Sept. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Beijing Childrens Hospital,Capital Medical University
Condition:
Soft tissue sarcoma
Ewing sarcoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-20
Target Sample Size: Experimental group:54;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj...